Literature DB >> 33351048

Gastroesophageal Reflux Disease: A Review.

John Maret-Ouda1,2, Sheraz R Markar1,3, Jesper Lagergren1,4.   

Abstract

Importance: Gastroesophageal reflux disease (GERD) is defined by recurrent and troublesome heartburn and regurgitation or GERD-specific complications and affects approximately 20% of the adult population in high-income countries. Observations: GERD can influence patients' health-related quality of life and is associated with an increased risk of esophagitis, esophageal strictures, Barrett esophagus, and esophageal adenocarcinoma. Obesity, tobacco smoking, and genetic predisposition increase the risk of developing GERD. Typical GERD symptoms are often sufficient to determine the diagnosis, but less common symptoms and signs, such as dysphagia and chronic cough, may occur. Patients with typical GERD symptoms can be medicated empirically with a proton pump inhibitor (PPI). Among patients who do not respond to such treatment or if the diagnosis is unclear, endoscopy, esophageal manometry, and esophageal pH monitoring are recommended. Patients with GERD symptoms combined with warning symptoms of malignancy (eg, dysphagia, weight loss, bleeding) and those with other main risk factors for esophageal adenocarcinoma, such as older age, male sex, and obesity, should undergo endoscopy. Lifestyle changes, medication, and surgery are the main treatment options for GERD. Weight loss and smoking cessation are often useful. Medication with a PPI is the most common treatment, and after initial full-dose therapy, which usually is omeprazole 20 mg once daily, the aim is to use the lowest effective dose. Observational studies have suggested several adverse effects after long-term PPI, but these findings need to be confirmed before influencing clinical decision making. Surgery with laparoscopic fundoplication is an invasive treatment alternative in select patients after thorough and objective assessments, particularly if they are young and healthy. Endoscopic and less invasive surgical techniques are emerging, which may reduce the use of long-term PPI and fundoplication, but the long-term safety and efficacy remain to be scientifically established. Conclusions and Relevance: The clinical management of GERD influences the lives of many individuals and is responsible for substantial consumption of health care and societal resources. Treatments include lifestyle modification, PPI medication, and laparoscopic fundoplication. New endoscopic and less invasive surgical procedures are evolving. PPI use remains the dominant treatment, but long-term therapy requires follow-up and reevaluation for potential adverse effects.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33351048     DOI: 10.1001/jama.2020.21360

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  23 in total

Review 1.  Excess Body Weight and Gastroesophageal Reflux Disease.

Authors:  Andreas Thalheimer; Marco Bueter
Journal:  Visc Med       Date:  2021-05-07

Review 2.  Esophageal Dysfunction in Post-lung Transplant: An Enigma.

Authors:  Aditya V Jadcherla; Kevin Litzenberg; Gokulakrishnan Balasubramanian
Journal:  Dysphagia       Date:  2022-08-12       Impact factor: 2.733

3.  Mechanisms of Chinese Medicine in Gastroesophageal Reflux Disease Treatment: Data Mining and Systematic Pharmacology Study.

Authors:  Hao-Yu Chen; Qi Li; Ping-Ping Zhou; Tian-Xiao Yang; Shao-Wei Liu; Teng-Fei Zhang; Zhen Cui; Jing-Jing Lyu; Yan-Gang Wang
Journal:  Chin J Integr Med       Date:  2022-08-23       Impact factor: 2.626

4.  Safe implementation of transoral incisionless fundoplication as a new technique in a tertiary care center.

Authors:  Shivanand Bomman; Sofya Malashanka; Adil Ghafoor; David J Sanders; Shayan Irani; Richard A Kozarek; Andrew Ross; Michal Hubka; Rajesh Krishnamoorthi
Journal:  Clin Endosc       Date:  2022-08-17

5.  LAPAROSCOPIC ANTIREFLUX SURGERY: ARE OLD QUESTIONS ANSWERED? SHOULD IT BE USED CONJOINED WITH ENDOSCOPIC THERAPY FOR BARRETT'S ESOPHAGUS?

Authors:  Shiwei Han; Donald E Low
Journal:  Arq Bras Cir Dig       Date:  2022-06-24

6.  Fundoplication is superior to medical therapy for Barrett's esophagus disease regression and progression: a systematic review and meta-analysis.

Authors:  H Wilson; V Mocanu; W Sun; J Dang; U Jogiat; J Kung; N Switzer; C Wong; S Karmali
Journal:  Surg Endosc       Date:  2021-05-18       Impact factor: 4.584

7.  On-demand Versus Continuous Maintenance Treatment of Gastroesophageal Reflux Disease With Proton Pump Inhibitors: A Systematic Review and Meta-analysis.

Authors:  Seung Joo Kang; Hye-Kyung Jung; Chung Hyun Tae; Seung Young Kim; Kwang Jae Lee
Journal:  J Neurogastroenterol Motil       Date:  2022-01-30       Impact factor: 4.924

Review 8.  Current Advancement on the Dynamic Mechanism of Gastroesophageal Reflux Disease.

Authors:  Zhi Zheng; Yuxi Shang; Ning Wang; Xiaoye Liu; Chenglin Xin; Xiaosheng Yan; Yuhao Zhai; Jie Yin; Jun Zhang; Zhongtao Zhang
Journal:  Int J Biol Sci       Date:  2021-10-03       Impact factor: 6.580

9.  Reviewing the User-Centered Design Process for a Comprehensive Gastroesophageal Reflux Disease (GERD) App.

Authors:  Min Ji Kim; Sarah Schroeder; Shuan Chan; Kyle Hickerson; Yi-Ching Lee
Journal:  Int J Environ Res Public Health       Date:  2022-01-20       Impact factor: 3.390

10.  Identification of independent risk factors for intraoperative gastroesophageal reflux in adult patients undergoing general anesthesia.

Authors:  Xiao Zhao; Shi-Tong Li; Lian-Hua Chen; Kun Liu; Ming Lian; Hui-Juan Wang; Yi-Jiao Fang
Journal:  World J Clin Cases       Date:  2021-12-16       Impact factor: 1.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.